Laparoscopic Assisted Dismembered Pyeloplasty Versus Open Pyeloplasty in (UPJO) With Poorly Function Kidney in Pediatrics

Sponsor
Al-Azhar University (Other)
Overall Status
Completed
CT.gov ID
NCT05953571
Collaborator
University Hospital Fattouma Bourguiba (Other)
65
1
17.7
3.7

Study Details

Study Description

Brief Summary

The management of kidneys with poor function less than 10% has been the subject of debate for more than a decade. Some authors have recommended nephrectomy while others favor renal salvage (pyeloplasty). the investigators reported their experience of lap assisted pyeloplasty in poorly functioning kidneys in the pediatric age group, concerning on the benefits of a minimally invasive method for repair of UPJO, in comparison with open approach.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Dismembered Pyeloplasty

Study Design

Study Type:
Observational
Actual Enrollment :
65 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Laparoscopic Assisted Dismembered Pyeloplasty Versus Open Pyeloplasty in (UPJO) With Poorly Function Kidney in Pediatrics
Actual Study Start Date :
Jan 8, 2022
Actual Primary Completion Date :
Mar 8, 2023
Actual Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
GroupA

Laparoscopic assisted dismembered pyeloplasty in poorly function kidney

Procedure: Dismembered Pyeloplasty
dismembered Anderson-Hynes repair was performed using 5/0 absorbable suture.

Group B

Open dismembered pyeloplasty in poorly function kidney

Procedure: Dismembered Pyeloplasty
dismembered Anderson-Hynes repair was performed using 5/0 absorbable suture.

Outcome Measures

Primary Outcome Measures

  1. Renal function [12 months post-operative]

    Split renal function by Renal scan (DTPA) %

  2. Measurments A-P renal pelvis diameter [12 months]

    ultrasound measuerment of renal pelvis diameter by mm

Secondary Outcome Measures

  1. operative time [one month]

    operative time by minutes

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Months to 14 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with hydronephrosis diagnosed as UPJO

  • Antero-Posterior pelvic diameter more than 20 mm

  • renal function equal or less than 10%,

  • corrected by laparoscopic assisted or open pyeloplasty

Exclusion Criteria:
  • Patients with ureteral dilatation (VUR),

  • renal function more than 10%,

  • acquired and recurrent cases

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mohammad Daboos Cairo Select Egypt 115678

Sponsors and Collaborators

  • Al-Azhar University
  • University Hospital Fattouma Bourguiba

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mohammad Daboos, Pediatric Surgery Department, Al-Azhar University., Al-Azhar University
ClinicalTrials.gov Identifier:
NCT05953571
Other Study ID Numbers:
  • 8-1-2022-000048
First Posted:
Jul 20, 2023
Last Update Posted:
Jul 20, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mohammad Daboos, Pediatric Surgery Department, Al-Azhar University., Al-Azhar University

Study Results

No Results Posted as of Jul 20, 2023